retatrutide clinical trial results weight loss ๐ PHASE 3 RESULTS: BY THE NUMBERS Let's break down what the trials actually showed: SURMOUNT-1 (68 weeks): โข Average loss: 24% of body weight โข Participants Eli Lilly's Retatrutide Phase 3
Description
The GLP-1 Boom: Whats Fueling It Youve seen the headlines
For some people, the thoughts are simply stronger and more persistent than for others

ODB (Ontario Drug Benefit) Ontarios provincial drug coverage program

I'll link to these studies for you

Furthermore, early safety trials that included kidney outcomes as secondary endpoints hinted at potential renal benefits associated with these medication classes

It is a shift in mindset
